TDZD-8
Catalog No. A11941
TDZD-8是一种非ATP竞争性GSK-3β抑制剂,IC50为2 μM;对CDK1, casein kinase II, PKA和PKC具有最低限度的抑制效果。
Catalog Num | A11941 |
---|---|
M. Wt | 222.3 |
Formula | C10H10N2SO2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 327036-89-5 |
Synonyms | TDZD8 |
SMILES | CN1C(=O)N(C(=O)S1)CC2=CC=CC=C2 |
TDZD-8是一种非ATP竞争性GSK-3β抑制剂,IC50为2 μM;对CDK1, casein kinase II, PKA和PKC具有最低限度的抑制效果。
In vitro | DMSO | 38 mg/mL (170.97 mM) | |
Water | Insoluble | ||
Ethanol | 38 mg/mL (170.97 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 44.98 mL | 224.92 mL | 449.84 mL |
0.5 mM | 9 mL | 44.98 mL | 89.97 mL |
1 mM | 4.5 mL | 22.49 mL | 44.98 mL |
5 mM | 0.9 mL | 4.5 mL | 9 mL |
*The above data is based on the productmolecular weight 222.3. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.